Putting Science to Work

In the News

Syngene Q4 profit up 18% to Rs 66 crore

Mint-27/04/2016. The profit was notched up on a 28% increase in Syngene’s revenue to Rs334 crore from Rs254 crore

Discovery Chemistry Discovery Biology Safety Assessment Large Molecule Development Chemical Development Formulation Development Stability Studies Polymer Research Integrated Discovery & Development Clinical Development Services Bioinfomatics Antibody Drug Conjugates Oligonucleotide Synthesis Contact Us

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

FB Side
Inactive